Hyperkalemia alters EDHF-mediated hyperpolarization and relaxation in coronary arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 40, Issue 2, 1996, Pages

  He, Guo Wei ^a   Yang, Cheng Qin ^b   Graier, Wolfgang F ^b,c   Yang, Jian An ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bradykinin; Calcium ionophore; Coronary artery; Endothelium derived hyperpolarizing factor; Endothelium derived relaxing factor; Potassium channels

Indexed keywords

EID: 0029756782     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aeba, R., R. J. Keenan, R. L. Hardesty, S. A. Yousem, I. Hamamoto, and B. P. Griffith. University of Wisconsin solution for pulmonary preservation in a rat transplant model. Ann. Thorac. Surg. 53: 240-246, 1992.
2. 2-Adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br. J. Pharmacol. 88: 767-77, 1986.
3. Brayden, J. E. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H668-H673, 1990.
4. Chen, G., H. Suzuki, and A. H. Weston. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95: 1165-1174, 1988.
5. Chen, G., Y. Yamamoto, K. Miwa, and H. Suzuki. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1888-H1892, 1991.
6. Evora, P. R. B., P. J. Pearson, and H. V. Schaff. Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries. J. Thorac. Cardiovasc. Surg. 104: 1365-1374, 1992.
7. Feletou, M., and P. M. Vanhoutte. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93: 515-524, 1988.
8. 2+ entry in human and bovine endothelial cells. J. Physiol. Lond. 482: 259-274, 1995.
9. Hasunuma, K., T. Yamaguchi, D. M. Rodman, R. F. O'Brien, and I. F. McMurtry. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L97-L104, 1991.
10. He, G. W., J. A. Angus, and F. L. Rosenfeldt. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J. Cardiovasc. Pharmacol. 12: 12-22, 1988.
11. He, G. W., B. Buxton, F. Rosenfeldt, and J. A. Angus. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. Circulation 80, Suppl. I: I-141-I-150, 1989.
12. 1-adrenoceptor mediated contraction in the human internal mammary artery. J. Cardiovasc. Pharmacol. 21: 256-263, 1993.
13. He, G. W., C. Q. Yang, I. M. Rebeyka, and G. J. Wilson. Effect of neonatal endothelium and smooth muscle to hyperkalemic cardioplegic solutions. J. Heart. Lung Transplant. 14, 92-101, 1995.
14. He, G. W., C. Q. Yang, G. J. Wilson, and I. M. Rebeyka. Tolerance of coronary endothelium and smooth muscle to hyperkalemia. Ann. Thoracic. Surg. 57, 682-688, 1994.
15. Holzmann, S., W. R. Kukovetz, W. Windischhofer, E. Paschke, and W. F. Graier. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J. Cardiovasc. Pharmacol. 23: 747-756, 1994.
16. Jeevanandam, V., J. S. Auteri, J. A. Sanchez, M. L. Barr, G. Y. Ott, D. Hsu, C. Marboe, C. R. Smith, and E. A. Rose. Improved heart preservation with University of Wisconsin solution: experimental and preliminary human experience. Circulation 84, Suppl. III: III-324-III-328, 1991.
17. Jeevanandam, V., M. L. Barr, J. S. Auteri, J. A. Sanchez, J. Fong, F. A. Schenkel, C. Marboe, R. E. Michler, C. R. Smith, and E. A. Rose. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. J. Thorac. Cardiovasc. Surg. 103: 194-199, 1992.
18. Keshavjee, S. H., F. Yamazaki, P. F. Cardoso, D. I. McRitchie, G. A. Patterson, and J. D. Cooper. A method for safe twelve-hour pulmonary preservation. J. Thorac. Cardiovasc. Surg. 98: 529-534, 1989.
19. Nagao, T., and P. M. Vanhoutte. Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1034-H1037, 1991.
20. Nilsson, F. N., Miller, V. M., P. M. Vanhoutte, and C. G. A. McGregor. Methods of cardiac preservation alter the function of the endothelium in porcine coronary arteries. J. Thorac. Cardiovasc. Surg. 102: 923-930, 1991.
21. Saldanha, C., and D. J. Hearse. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J. Thorac. Cardiovasc. Surg. 98: 783-787, 1989.
22. sα independent of phosphorylation by protein kinase A. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1460-H1465, 1993.
23. Ca channel activity from pig coronary artery. Am. J. Physiol. 262 (Cell Physiol. 31): C708-C713, 1992.
24. Siegel, G., A. Walter, F. Schnalke, A. Schmidt, E. Buddecke, G. Loirand, and G. Stock. Potassium channel activation, hyperpolarization, and vascular relaxation. Z. Kardiol. 80, Suppl. 7: 9-24, 1991.
25. Stein, D. G., L. C. Permut, D. C. Drinkwater, Jr., S. Bhuta, P. Chang, A. Wu, and H. Laks. Complete functional recovery after 24-hour heart preservation with University of Wisconsin solution and modified reperfusion. Circulation 84, Suppl. III: III-316-III-323, 1991.
26. Taylor, S. G., and A. H. Weston. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends. Pharmacol. Sci. 9: 72-74, 1988.